Showing results (601-610 of 609) with videos related to
Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 609 results.
Nature Neuroscience|August 1, 2022
Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular functionChia-Chen Liu, Jing Zhao, Yuan Fu, et al.Nature Genetics|March 14, 2017
Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humansHsiang-Chih Lu, Qiumin Tan, Maxime W C Rousseaux, et al.Journal of the American College of Cardiology|January 25, 2023
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and AtherosclerosisAndrej Ćorović, Christopher Wall, Meritxell Nus, et al.Nature Neuroscience|October 27, 2022
Mapping neurotransmitter systems to the structural and functional organization of the human neocortexJustine Y Hansen, Golia Shafiei, Ross D Markello, et al.Neuron|August 18, 2017
TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule DynamicsIan R Mackenzie, Alexandra M Nicholson, Mohona Sarkar, et al.Science Translational Medicine|September 29, 2021
<i>APOE3</i>-Jacksonville (V236E) variant reduces self-aggregation and risk of dementiaChia-Chen Liu, Melissa E Murray, Xia Li, et al.Science Translational Medicine|October 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.Brain : a Journal of Neurology|August 14, 2025
Connectivity as a universal predictor of tau progression in atypical Alzheimer's diseaseHannah de Bruin, Colin Groot, Henryk Barthel, et al.Science Translational Medicine|March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.Pageof 61